Leerink Partners analyst Roanna Ruiz has maintained their bullish stance on LXRX stock, giving a Buy rating yesterday.Invest with Confidence: ...

Lexicon Pharmaceuticals Inc (LXRX) stock saw a decline, ending the day at $0.83 which represents a decrease of $-0.10 or -10.75% from the prior close of $0.93. The stock opened at $0.94 and touched a ...

With new drug development, a significant increase in sales, and high potential with Mounjaro and Zepbound, here’s what we think of Eli Lilly’s stock ...

The banner said it all. It’s referring to Spurs, aka “Dr Tottenham”, but in particular, the Scrooge-like regime of Daniel Levy. Held aloft at the last home game – a humbling defeat to relegation- ...

Courage is needed to fight back against the unabashed attack on civil and human rights that the Trump administration has ...

It is the dark matter of conversation, the white space around a poem. For Rilke, listening is receiving the divine ...

Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics ...